Literature DB >> 8145853

Calmodulin interacts with amphiphilic peptides composed of all D-amino acids.

P J Fisher1, F G Prendergast, M R Ehrhardt, J L Urbauer, A J Wand, S S Sedarous, D J McCormick, P J Buckley.   

Abstract

Calmodulin binds to amphiphilic, helical peptides of a variety of amino-acid sequences. These peptides are usually positively charged, although there is spectroscopic evidence that at least one neutral peptide binds. The complex between calmodulin and one of its natural target peptides, the binding site for calmodulin on smooth muscle myosin light-chain kinase (RS20), has been investigated by crystallography and NMR which have characterized the interactions between the ligand and the protein. From these data, it appears that the calmodulin-binding surface is sterically malleable and van der Waals forces probably dominate the binding. To explore further this apparently permissive binding, we investigated the chiral selectivity of calmodulin using synthesized analogues of melittin and RS20 that consisted of only D-amino acids. Fluorescence and NMR measurements show that D-melittin and D-RS20 both bind avidly to calmodulin, probably in the same general binding site as that for peptides having all L-amino acids. The calmodulin-peptide binding surface is therefore remarkably tolerant sterically. Our results suggest a potentially useful approach to the design of non-hydrolysable or slowly hydrolysable intracellular inhibitors of calmodulin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8145853     DOI: 10.1038/368651a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  9 in total

1.  Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37.

Authors:  Y Elaine Lau; Dawn M E Bowdish; Celine Cosseau; Robert E W Hancock; Donald J Davidson
Journal:  Am J Respir Cell Mol Biol       Date:  2005-12-09       Impact factor: 6.914

2.  A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.

Authors:  M Pritsker; P Jones; R Blumenthal; Y Shai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 3.  Protein complexes studied by NMR spectroscopy.

Authors:  A J Wand; S W Englander
Journal:  Curr Opin Biotechnol       Date:  1996-08       Impact factor: 9.740

4.  A nonnatural transcriptional coactivator.

Authors:  O Nyanguile; M Uesugi; D J Austin; G L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide.

Authors:  P Díaz-Achirica; J Ubach; A Guinea; D Andreu; L Rivas
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

6.  The receptor-associated protein (RAP) binds calmodulin and is phosphorylated by calmodulin-dependent kinase II.

Authors:  C M Petersen; L Ellgaard; A Nykjaer; F Vilhardt; H Vorum; H C Thøgersen; M S Nielsen; C Jacobsen; S K Moestrup; J Gliemann
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

7.  Hydroxyl radical probe of the calmodulin-melittin complex interface by electrospray ionization mass spectrometry.

Authors:  Jason W H Wong; Simin D Maleknia; Kevin M Downard
Journal:  J Am Soc Mass Spectrom       Date:  2005-02       Impact factor: 3.109

8.  Ca2+-calmodulin inhibits tail-anchored protein insertion into the mammalian endoplasmic reticulum membrane.

Authors:  Sarah Hassdenteufel; Nico Schäuble; Patrizia Cassella; Pawel Leznicki; Anika Müller; Stephen High; Martin Jung; Richard Zimmermann
Journal:  FEBS Lett       Date:  2011-10-12       Impact factor: 4.124

Review 9.  Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.

Authors:  Kelly C L Mulder; Loiane A Lima; Vivian J Miranda; Simoni C Dias; Octávio L Franco
Journal:  Front Microbiol       Date:  2013-10-31       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.